Taysha Gene Therapies
Texas, US · Founded 2019 · 1 known investors
Taysha Gene Therapies develops gene therapies for patients with central nervous system diseases caused by single-gene mutations, with an initial focus on Rett syndrome. The company targets rare monogenic CNS diseases with the goal of transforming treatment outcomes for affected patients and families.
Founders & leadership
RS
R.A. Session IIExecutive Officer, Director
PB
Paul B. ManningDirector
SN
Sean NolanDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements$150MraisedAug 2023 · 42 investors · Biotechnology
Rule 506(b)$30MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)$96MraisedAug 2020 · 26 investors · Biotechnology
Rule 506(b)$18MraisedMay 2020 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.